Extended-Release Oxybutynin for the Treatment of Neurogenic Detrusor Overactivity

Clinical trial NCT01796548 · TERMINATED

Trial details

NCT number: NCT01796548
Sponsor: Janssen-Cilag Ltd.,Thailand
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Detrusor Function, Overactive

Start date: 2008-12-01
Primary completion: 2010-12-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.